[After a heart infarct].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D012008:Recurrence; D012306:Risk
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants
Na het hartinfarct.